Daijiworld Media Network - New Delhi

New Delhi, Nov 8: The Central Drugs Standard Control Organisation (CDSCO) has ordered state drug controllers to conduct thorough inspections of all pharmaceutical manufacturing units to ensure compliance with international good manufacturing practices (GMP) by January 1, 2026.

In a directive issued on November 7, Drug Controller General of India (DCGI) Rajeev Raghuvanshi instructed state and Union Territory regulators to submit monthly reports detailing their inspection findings and follow-up actions. “In case any manufacturing unit is found non-complying with the requirements of revised Schedule M during inspections, strict action shall be initiated,” the letter stated.

The revised Schedule M norms, introduced in 2023, align India’s pharmaceutical

See Full Page